We are live on ! Find out more
ICUI icon

ICU Medical

267 hedge funds and large institutions have $3.7B invested in ICU Medical in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 105 increasing their positions, 70 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

113% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $7.59M

59% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 27

50% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 70

22% more capital invested

Capital invested by funds: $3.04B → $3.7B (+$657M)

2.83% more ownership

Funds ownership: 92.83%95.66% (+2.8%)

3% more funds holding

Funds holding: 260267 (+7)

Holders
267
Holders Change
+7
Holders Change %
+2.69%
% of All Funds
5.26%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
43
Increased
105
Reduced
70
Closed
27
Calls
$16.1M
Puts
$7.59M
Net Calls
+$8.55M
Net Calls Change
-$8.84M
Name Holding Trade Value Shares
Change
Change in
Stake
EAM
26
Eagle Asset Management
Florida
$26.1M +$4.32M +25,128 +22%
Charles Schwab
27
Charles Schwab
California
$25.8M +$997K +5,794 +4%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$20.7M +$19.1M +110,749 New
GT
29
Glenmede Trust
Pennsylvania
$20.5M -$2.31M -13,402 -11%
SCP
30
Sandhill Capital Partners
New York
$20.3M +$308K +1,790 +2%
PVI
31
Pura Vida Investments
New York
$19.3M +$1.86M +10,820 +12%
Invesco
32
Invesco
Georgia
$18.1M -$4.44M -25,776 -21%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$17.7M -$9.08M -52,740 -36%
Ameriprise
34
Ameriprise
Minnesota
$16.3M +$1.47M +8,545 +11%
RJA
35
Raymond James & Associates
Florida
$16.2M -$5.62M -32,656 -27%
Principal Financial Group
36
Principal Financial Group
Iowa
$15.6M -$14.1K -82 -0.1%
AQR Capital Management
37
AQR Capital Management
Connecticut
$15.5M -$4.31M -25,049 -23%
TA
38
Tamarack Advisers
California
$13M +$6.02M +35,000 +100%
GH
39
GAM Holding
Switzerland
$12.7M
AAM
40
AMI Asset Management
California
$12.4M -$1.19M -6,922 -9%
PPA
41
Parametric Portfolio Associates
Washington
$12.2M +$3.5M +20,322 +45%
Bank of America
42
Bank of America
North Carolina
$12.1M -$2.42M -14,036 -18%
WP
43
Woodline Partners
California
$11.7M +$10.8M +62,571 New
Fisher Asset Management
44
Fisher Asset Management
Washington
$11.4M
Morgan Stanley
45
Morgan Stanley
New York
$11.4M +$9.6M +55,760 +1,100%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$11.2M -$547K -3,181 -5%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$11M -$258K -1,500 -2%
GF
48
Gabelli Funds
New York
$10.2M -$51.6K -300 -0.5%
Goldman Sachs
49
Goldman Sachs
New York
$10M -$2.04M -11,847 -18%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$9.88M -$94.3K -548 -1%

ICUI Hedge Fund Activity: Q4 2019 in Review

267 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q4 2019, worth a combined $3.7B — up 22% from $3.04B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ICUI positions and 27 closed out — a net gain of 16 holders — while 105 added to existing stakes and 70 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $39.9M. The largest seller was Fidelity Investments, cutting an estimated $63.7M.

  • 267 institutional investors held ICU Medical (ICUI) as of Q4 2019, up from 260 in Q3 2019.
  • Funds reported $3.7B of ICU Medical stock for Q4 2019, up 22% quarter-over-quarter.
  • 43 funds opened new ICU Medical positions in Q4 2019 and 27 closed out, a net change of +16 holders.
  • The largest ICU Medical buyer in Q4 2019 was Point72 Asset Management, an estimated $39.9M added.
  • The largest ICU Medical seller in Q4 2019 was Fidelity Investments, an estimated $63.7M sold.

Based on aggregated 13F filings for Q4 2019.